HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Published online before print November 5, 2007

This Article Full Text (Reprint (PDF)) All Versions of this Article: jlb.0607-408v1 83/2/245    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Björkman, L. Articles by Dahlgren, C. Search for Related Content PubMed PubMed Citation Articles by Björkman, L. Articles by Dahlgren, C.

© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0607-408

Received for publication June 12, 2007.
Revised September 19, 2007.
Accepted for publication September 19, 2007.

Article

Serum amyloid A mediates human neutrophil production of reactive oxygen species through a receptor independent of formyl peptide receptor like-1

Lena Björkman ^*@, Jennie Karlsson ^*, Anna Karlsson ^*, Marie-Josèphe Rabiet , Francois Boulay , Huamei Fu ^*, Johan Bylund ^*, and Claes Dahlgren ^*

*Department of Rheumatology and Inflammation Research, The Sahlgrenska Academy at Göteborg University, Sweden; CEA, DSV, iRTSV, Laboratoire Biochimie et Biophysique des Systèmes Intégrés, Grenoble, France; CNRS, UMR 5092, Grenoble, France; and Université Joseph Fourier, Grenoble, France

^@ To whom correspondence should be addressed. E-mail: lena.i.bjorkman{at}vgregion.se.

	Abstract

Serum amyloid A (SAA) is one of the acute-phase reactants, a group of plasma proteins that increases immensely in concentration during microbial infections and inflammatory conditions, and a close relationship between SAA levels and disease activity in rheumatoid arthritis (RA) has been observed. RA is an inflammatory disease, where neutrophils play important roles, and SAA is thought to participate in the inflammatory reaction by being a neutrophil chemoattractant and inducer of proinflammatory cytokines. The biological effects of SAA are reportedly mediated mainly through formyl peptide receptor like-1 (FPRL1), a G protein-coupled receptor (GPCR) belonging to the formyl peptide receptor family. Here, we confirmed the affinity of SAA for FPRL1 by showing that stably transfected HL-60 cells expressing FPRL1 were activated by SAA and that the response was inhibited by the use of the FPRL1-specific antagonist WRWWWW (WRW4). We also show that SAA activates the neutrophil NADPH-oxidase and that a reserve pool of receptors is present in storage organelles mobilized by priming agents such as TNF- and LPS from Gram-negative bacteria. The induced activity was inhibited by pertussis toxin, indicating the involvement of a GPCR. However, based on FPRL1-specific desensitization and use of FPRL1 antagonist WRW4, we found the SAA-mediated effects in neutrophils to be independent of FPRL1. Based on these findings, we conclude that SAA signaling in neutrophils is mediated through a GPCR, distinct from FPRL1. Future identification and characterization of the SAA receptor could lead to development of novel, therapeutic targets for treatment of RA.

Key Words: FPRL1 • G protein-coupled receptor • WRW4 • rheumatoid arthritis

This article has been cited by other articles:

				D. El Kebir, L. Jozsef, and J. G. Filep Opposing regulation of neutrophil apoptosis through the formyl peptide receptor-like 1/lipoxin A4 receptor: implications for resolution of inflammation J. Leukoc. Biol., September 1, 2008; 84(3): 600 - 606. [Abstract] [Full Text] [PDF]